MoneyWorks4Me

Anlon Healthcare - Quaterly Results

31 Jul 2026 Evaluate
The sales declined to Rs. 309.76 millions for the June 2026 quarter as compared to Rs. 332.97 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended June 2026 rise to 35.21% to Rs. 47.96  millions  compared to R. 35.47 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 75.25 millions from 62.51 millions in the quarter ended June 2026.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 309.76 332.97 -6.97 309.76 332.97 -6.97 1764.99 1202.87 46.73
Other Income 0.60 0.12 400.00 0.60 0.12 400.00 2.54 1.69 50.30
PBIDT 75.25 62.51 20.38 75.25 62.51 20.38 463.92 323.77 43.29
Interest 9.64 8.20 17.56 9.64 8.20 17.56 43.53 37.15 17.17
PBDT 65.61 54.31 20.81 65.61 54.31 20.81 420.39 286.62 46.67
Depreciation 6.58 4.27 54.10 6.58 4.27 54.10 13.63 17.74 -23.17
PBT 59.03 50.04 17.97 59.03 50.04 17.97 406.76 268.88 51.28
TAX 11.07 14.57 -24.02 11.07 14.57 -24.02 128.68 63.70 102.01
Deferred Tax -4.17 -0.22 1795.45 -4.17 -0.22 1795.45 14.67 -1.75 -938.29
PAT 47.96 35.47 35.21 47.96 35.47 35.21 278.08 205.18 35.53
Equity 1063.00 398.51 166.74 1063.00 398.51 166.74 531.52 398.52 33.37
PBIDTM(%) 24.29 18.77 29.40 24.29 18.77 29.40 26.28 26.92 -2.35
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..